1. Santoro AF, Ferraris CM, Aghvinian M, Aurpibul L, et al.
   Acceptability and Feasibility of Genetic Testing to Assess Risk of HIV-Associated Neurocognitive Impairment among Thai Adolescents and Young Adults.
   AIDS Res Hum Retroviruses 2023.
   


2. Belaunzaran-Zamudio PF, Naranjo L, Caro-Vega Y, Castillo-Mancilla JR, et al.
   Incomplete ART Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV-infection in Mexico.
   AIDS Res Hum Retroviruses 2023.
   


3. Ramos-Ruperto L, Busca-Arenzana C, Diez-Vidal A, Robles-Marhuenda A, et al.
   PREVALENCE AND TEMPORAL TRENDS OF AUTOIMMUNE DISEASES IN PEOPLE LIVING WITH HIV.
   AIDS Res Hum Retroviruses 2023.
   


4. Ahrens K, Sharbaugh M, Jarlenski MP, Tang L, et al.
   Prevalence of testing for HIV, HBV, and HCV among Medicaid enrollees treated with medications for opioid use disorder in 11 states, 2016-2019.
   Clin Infect Dis 2023.
   


5. Zalla LC, Cole SR, Eron JJ, Adimora AA, et al.
   Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US.
   JAMA 2023;329:52-62.
   


6. Hachfeld A, Atkinson A, Stute P, Calmy A, et al.
   Does menopause transition influence viral suppression and adherence in Women living with HIV?
   J Acquir Immune Defic Syndr 2023.
   


7. White JA, Wu F, Yasin S, Moskovljevic M, et al.
   Clonally expanded HIV-1 proviruses with 5'-Leader defects can give rise to nonsuppressible residual viremia.
   J Clin Invest 2023.
   


8. Shiau S, Jacobson DL, Huo Y, Kacanek D, et al.
   Unique profile of inflammation and immune activation in pregnant people with HIV in the United States.
   J Infect Dis 2023.
   


9. Phillips S, Cornall AM, Molano M, Jin F, et al.
   Performance of human papillomavirus (HPV) attribution algorithms to predict causative genotypes in anal high-grade lesions.
   J Infect Dis 2023.
   


10. Hall SA, Burns GS, Mooney BJ, Millen R, et al.
    Hepatitis B Virus Flares following Nucleot(s)ide Analogue Cessation Are Associated with Activation of TLR Signalling Pathways.
    J Infect Dis 2022.
    


11. Srichawla BS, Garcia-Dominguez MA, Zia S.
    Secondary Complications and Management Strategies in Human Monkeypox: A Case Series.
    J Med Virol 2022.
    


12. Temerozo JR, Ferreira PLC, Linhares-Lacerda L, Vieira RC, et al.
    Interleukin-27 Promotes Divergent Effects on HIV-1 Infection in Peripheral Blood Mononuclear Cells through BST-2/Tetherin.
    J Virol 2023.
    


13. Tan ST, Kwan AT, Rodriguez-Barraquer I, Singer BJ, et al.
    Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.
    Nat Med 2023.
    


14. Alfadhli A, Romanaggi C, Barklis RL, Barklis E, et al.
    Analysis of HIV-1 envelope cytoplasmic tail effects on viral replication.
    Virology 2023;579:54-66.
    

Display articles in

• Abstract format
• Medline format